Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Tempus AI (TEM) Shares Issued (2023 - 2025)

Tempus AI (TEM) reported Shares Issued of $195.5 million for Q3 2025, up 151.18% on a QoQ basis from -$382.0 million in Q4 2024.

Tempus AI (TEM) has 3 years of Shares Issued data on file, last reported at $195.5 million in Q3 2025.

  • Quarterly Shares Issued changed N/A year-over-year to $195.5 million in Q3 2025, while the trailing twelve-month figure through Dec 2025 was -$186.5 million (up 50.64% YoY) and the FY2023 annual result came in at $4.2 million, changed N/A from the prior year.
  • Shares Issued grew to $195.5 million in Q3 2025 per TEM's latest filing, from -$382.0 million in the prior quarter.
  • Across five years, Shares Issued topped out at $195.5 million in Q3 2025 and bottomed at -$382.0 million in Q4 2024.
  • The 3-year median for Shares Issued is $4.2 million (2023), against an average of -$60.7 million.
  • Peak annual rise in Shares Issued reached 9144.54% in 2024, while the deepest fall reached 9144.54% in 2024.
  • Tracing TEM's Shares Issued over 3 years: stood at $4.2 million in 2023, then tumbled by 9144.54% to -$382.0 million in 2024, then surged by 151.18% to $195.5 million in 2025.
  • Per Business Quant, the three latest TEM Shares Issued figures stand at $195.5 million (Q3 2025), -$382.0 million (Q4 2024), and $4.2 million (Q4 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Issued (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn 13.87 Mn
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn 12.09 Mn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn 418,000.00
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn 410,000.00
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn -3.13 Mn
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn 2.41 Mn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn 273,000.00
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn 774,000.00
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn 7.76 Mn
10 Tempus AI 9.58 Mn -629.49 Mn 323.00 Mn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 195.50 Mn
Sep 30, 2025 195.50 Mn
Dec 31, 2024 -381.95 Mn
Dec 31, 2024 -381.95 Mn
Dec 31, 2023 4.22 Mn
Dec 31, 2023 4.22 Mn